Abbott Laboratories ABT
$88.30▼ -1.64% 24H
Super Investor & Insider
6
Fondi che lo detengono
#115
Rank consenso
8.6%
% dei portafogli
$411.7M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 2.1% | Buy | 1,758,160 | $180.5M |
| Jensen Investment Management · Jensen Investment Management | 3.01% | Reduce 20.66% | 1,486,036 | $152.6M |
| Mairs & Power · Mairs & Power | 0.76% | Add 1.93% | 721,778 | $74.1M |
| Dodge & Cox · Dodge & Cox | 0% | — | 17,324 | $1.8M |
| Polen Capital Management · Polen Capital Management | 0.01% | Reduce 99.62% | 15,081 | $1.5M |
| Thomas Russo · Gardner Russo & Quinn | 0.01% | — | 11,510 | $1.2M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Abbott Laboratories is a diversified healthcare company that discovers, develops, manufactures, and sells a comprehensive range of medical products and pharmaceuticals globally. The company operates through four primary segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medica…
SectorHealthcare
ExchangeNYSE
IndustryMedical Devices
CountryUnited States
Employees122,000
TickerABT
Statistics
Market Cap$153.79B
Revenue (TTM)$44.33B
Net Income$6.52B
Net Margin14.7%
EPS$3.72
P/E25.11
P/S3.46
P/B3.00
EV/EBITDA15.56
ROE12.3%
Dividend Yield2.86%
Price$88.30
Data: Twelve Data · Revenue = mcap / P/S